Author

M. R. Holbrook

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

S. Dixit· 2 shared A. Cooper· 1 shared A. Pegu· 1 shared C. Dacon· 1 shared C. Schmaljohn· 1 shared C. Tucker· 1 shared C.-C. D. Lee· 1 shared C.-W. Pyo· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

S. Dixit

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivApr 11, 2022

Broadly neutralizing antibodies target the coronavirus fusion peptide

C. Dacon, C. Tucker, L. Peng…·J. Tan

The paper identifies six monoclonal antibodies that broadly neutralize coronaviruses by targeting the conserved fusion peptide.

DOI 10.1126/science.abq3773

𝕏 PostBluesky

ImmunologybioRxivMar 5, 2021

Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID 19) Virus-Neutralizing Antibodies in Human Clinical Samples

M. R. Holbrook, R. S. Bennett, E. N. Postnikova…·V. V. Lukin

The paper describes a modified fluorescence reduction neutralization assay for quantitatively assessing SARS-CoV-2 neutralizing antibodies in clinical samples, demonstrating its efficiency and accuracy.

DOI 10.3390/v13050893

humanproteomics

𝕏 PostBluesky